---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-26-022311"
form_type: "8-K"
ticker: "RCKT"
cik: "0001281895"
company_name: "ROCKET PHARMACEUTICALS, INC."
filed_at: "2026-05-21T10:02:22+00:00"
generated_at: "2026-05-21T10:08:09.532626+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Rocket Pharmaceuticals stockholders elect directors, ratify auditor, approve say-on-pay and stock option exchange

## Summary
- Seven director nominees elected; David P. Southwell received 43.2M for, 20.1M withheld (lowest support).
- Ratification of EisnerAmper as independent auditor: 79.2M for, 1.0M against, 0.6M abstain.
- Non-binding advisory vote on executive compensation approved: 61.4M for, 1.7M against, 0.2M abstain.
- Stock option exchange program approved with 45.6M for, 17.6M against (significant opposition).

## SEC filing metadata
- accession: 0001140361-26-022311
- form_type: 8-K
- ticker: RCKT
- cik: 0001281895
- company_name: ROCKET PHARMACEUTICALS, INC.
- filed_at: 2026-05-21T10:02:22+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1281895/000114036126022311/0001140361-26-022311-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1281895/000114036126022311/ef20074449_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-26-022311
- JSON: https://secwatch.observer/filing/0001140361-26-022311.json
- Plain text: https://secwatch.observer/filing/0001140361-26-022311.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.